Science and technologies

UCB is an R&D driven company, investing more than 20% of revenue in R&D every year. Research is the lifeblood of UCB's future and is vital to the organisation.

The strength of our science and technologies is based on

• a strong understanding of selected therapeutic areas and disease targets
• a novel and entrepreneurial use of discovery technologies for the development of breakthrough medicines
• embracing innovation in drug development to push the boundaries of R&D.

Fundamental to our philosophy is connecting science in new ways, notably chemistry and biology, to leverage the potential of these two disciplines.

Please use this section of the website to find examples of some of the innovative and proprietary science and technologies that UCB is deploying in its search for breakthrough medicines.